Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events.
OBJECTIVE
The study evaluated the associations between glycometabolic parameters at admission and during hospitalization and 2 year all-cause mortality risk in an unselected cohort of consecutive patients with diabetes admitted for unstable angina or non-Q-wave myocardial infarction to a university hospital during 1988-98.


RESULTS
A total of 713 consecutive patients with diabetes were included. During 2 years of follow-up, 242 (34%) patients died. All analyses were retrospective using prospectively collected clinical data. The primary study endpoint was 2 year all-cause mortality collected from the Swedish cause-specific mortality register. In unadjusted analyses, high admission blood glucose (highest vs. lowest quartile: hazard ratio (HR) 2.66; 95% confidence interval (CI) 1.83, 3.86) and hypoglycaemia recorded during hospitalization (hypoglycaemia vs. normal: HR 1.77; 95% CI 1.09, 2.86) were both significantly associated with increased 2 year all-cause mortality risk. These associations remained significant after multivariable adjustment.


CONCLUSIONS
In the setting of acute coronary syndromes (ACS) among patients with diabetes, hyperglycaemia on arrival and hypoglycaemia during hospitalization are both independently associated with worse adjusted all-cause 2 year mortality risk. These observations suggest that the avoidance of both hyper- and hypoglycaemia during ACS events may be of similar importance, and glucose modulation remains an important objective to address in future randomized trials.
Svensson
Ann-Marie
AM
Clinical Experimental Research Laboratory, Sahlgrenska University Hospital/Ostra, 416 85 Göteborg, Sweden. ann-marie.svensson@hjl.gu.se
McGuire
Darren K
DK
Abrahamsson
Putte
P
Dellborg
Mikael
M
D000368:Aged; D000789:Angina, Unstable / Q000401:mortality*; D015331:Cohort Studies; D003925:Diabetic Angiopathies / Q000401:mortality* / Q000517:prevention & control; D005260:Female; D006760:Hospitalization; D006801:Humans; D006943:Hyperglycemia / Q000401:mortality* / Q000517:prevention & control; D007003:Hypoglycemia / Q000401:mortality* / Q000517:prevention & control; D008297:Male; D009203:Myocardial Infarction / Q000401:mortality*; D011379:Prognosis; D011446:Prospective Studies; D013548:Sweden / Q000453:epidemiology; D013577:Syndrome